In addition, the accumulating evidence points to an essential role of the inflammatory component in the process of DCM.[20,21] Recent studies suggest that SGLT2 inhibitors may have anti-inflammatory effects. This evidence concerns the gene SLC5A2 and familial dilated cardiomyopathy.